A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NTHI SEC filings page.
NeOnc Technologies Holdings, Inc. (NTHI) reported $40K in revenue for fiscal year 2025, down 51.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 shows a development-stage business whose operating outflows were funded externally while liabilities expanded against shrinking assets.
In FY2025, financing cash flow of$20.9M nearly offset operating cash flow of-$20.4M , so reported cash movement was dominated by external funding rather than internally generated operations. At the same time, liabilities rose127.9% while assets fell17.4% , linking that funding pattern to a materially more burdened balance sheet.
FY2025 revenue was
Short-term liquidity weakened sharply: the current ratio fell from 0.2460 in FY2024 to 0.0693 in FY2025, indicating current assets cover only a small fraction of current obligations. Negative equity reached
Financial Health Signals
We do not publish a peer-relative financial health score for NeOnc Technologies Holdings, Inc., because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
NeOnc Technologies Holdings, Inc. scores -129.20, below the 1.81 distress threshold. The score is pulled down most by an operating loss of $58.2M against total assets of $2.8M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
NeOnc Technologies Holdings, Inc. passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) does not pass.
NeOnc Technologies Holdings, Inc. reported a net loss of $62.1M while operations used $20.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.
NeOnc Technologies Holdings, Inc. reported an operating loss of $58.2M against $2.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
NeOnc Technologies Holdings, Inc. generated $0 in revenue in Q3 2026. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
NeOnc Technologies Holdings, Inc. reported a net loss of $4.4M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
NeOnc Technologies Holdings, Inc. earned -$0.28 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2026.
Cash & Balance Sheet
NeOnc Technologies Holdings, Inc. held $6.2M in cash as of Q3 2026; no long-term debt figure is on record for that period.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
None of these metrics is reported for Q3 2026.
Capital Allocation
NeOnc Technologies Holdings, Inc. invested $1.3M in research and development in Q3 2026. This represents an increase of 82.9% from the same quarter a year earlier. Against the prior quarter it is down 50.7%.
Not reported for Q3 2026.
Not reported for Q3 2026.
NTHI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | N/A | N/A | N/A | N/A | $40K-7.0% | N/A |
| R&D Expenses | $1.3M+82.9% | $2.6M+291.2% | $1.3M+28.9% | $1.2M+15.6% | $715K-25.3% | $677K+71.7% | $998K+62.4% | $1.1M |
| SG&A Expenses | $637K-29.5% | $896K-9.0% | $489K+262.3% | N/A | $903K+270.6% | $984K+239.8% | $135K-1.7% | N/A |
| Operating Income | -$5.8Mn/m | -$14.1Mn/m | -$7.1Mn/m | -$13.7Mn/m | -$6.9Mn/m | -$5.7Mn/m | -$31.9Mn/m | -$2.1M |
| Interest Expense | $98K-88.8% | $234K+380.8% | $983K+218.1% | $1.3M | $870K | $49K-95.8% | $309K-77.7% | N/A |
| Net Income | -$4.4Mn/m | -$14.2Mn/m | -$8.8Mn/m | -$15.5Mn/m | -$8.6Mn/m | -$5.7Mn/m | -$32.3Mn/m | -$2.3M |
| EPS (Basic) | -$0.28n/m | -$0.58n/m | -$0.38n/m | -$0.72n/m | -$0.45n/m | -$0.30n/m | -$1.78n/m | -$0.13 |
| EPS (Diluted) | -$0.28n/m | -$0.58n/m | -$0.38n/m | -$0.72n/m | -$0.45n/m | -$0.30n/m | -$1.78n/m | -$0.13 |
| Diluted Shares (Avg) | 26M+34.2% | 25M+29.6% | 23M+28.4% | N/A | 19M+7.2% | 19M+14.4% | 18M+9.5% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, EBITDA, Income Tax.
NTHI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.3M+127.9% | $5.2M+75.1% | $3.3M-60.6% | $2.8M-17.4% | $4.1M | $3.0M | $8.4M | $3.4M |
| Current Assets | $8.5M+185.5% | $4.2M+153.4% | $2.1M-71.5% | $1.4M-36.7% | $3.0M | $1.7M | $7.4M | $2.2M |
| Cash & Equivalents | $6.2M+307.5% | $2.0M+1478.2% | $139K-97.5% | $59K-9.5% | $1.5M+13.4% | $125K-91.8% | $5.4M+108380.5% | $65K |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0 |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0 |
| Total Liabilities | $22.5M+41.4% | $23.8M+60.5% | $16.6M-8.3% | $20.3M+127.9% | $15.9M | $14.8M | $18.1M | $8.9M |
| Current Liabilities | $22.2M+42.7% | $23.5M+62.4% | $16.3M-9.8% | $20.0M+124.6% | $15.6M | $14.5M | $18.1M | $8.9M |
| Non-Current Liabilities | $235K-23.8% | $255K-22.1% | $274Kn/m | $291Kn/m | $309K | $327K | $0 | $0 |
| Total Equity | -$13.2Mn/m | -$18.5Mn/m | -$13.2Mn/m | -$17.5Mn/m | -$11.8Mn/m | -$11.8Mn/m | -$9.6Mn/m | -$5.5M |
| Retained Earnings | -$140.3Mn/m | -$135.8Mn/m | -$121.6Mn/m | -$112.8Mn/m | -$97.2M | -$88.6M | -$82.9M | -$50.6M |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
NTHI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$5.1Mn/m | -$4.8Mn/m | -$7.0Mn/m | -$3.6Mn/m | -$5.8Mn/m | -$5.3Mn/m | -$5.7M-3976.6% | -$954K |
| Stock-Based Compensation | $268K-94.7% | $5.7M+60.3% | $2.7M-84.3% | N/A | $5.0M | $3.5M | $17.4M | N/A |
| Financing Cash Flow | $9.3M+29.0% | $6.6Mn/m | $7.1M-35.9% | $2.6Mn/m | $7.2M+149.1% | $0-100.0% | $11.0Mn/m | -$315K |
Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
NTHI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | -79772.0% | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | -80835.2% | N/A |
| Return on Assets | -47.7%+163.3pp | -272.2%-82.1pp | -264.8%+118.1pp | -549.8%-483.9pp | -211.0% | -190.1% | -382.9% | -65.9% |
| Current Ratio | 0.38+0.2x | 0.18+0.1x | 0.13-0.3x | 0.07-0.2x | 0.19 | 0.11 | 0.41 | 0.25 |
| Asset Turnover | 0.00 | 0.00 | N/A | N/A | N/A | N/A | 0.00 | N/A |
Not reported in any period shown, so not listed: Gross Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: Shareholder equity is negative (-$17.5M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.07), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| NeOnc Technologies Holdings, Inc. NTHI | FY2025 | $40K | -$62.1M | N/A | $90.9M | — |
| PDS Biotechnology Corporation PDSB | FY2025 | N/A | -$34.5M | N/A | $95.4M | — |
| NRX Pharmaceuticals, Inc. NRXP | FY2025 | $1.2M | -$28.6M | N/A | $95.3M | 44/100 |
| Cellectis S.A. CLLS | FY2025 | $72.9M | -$67.6M | -92.7% | $92.8M | 78/100 |
| Genelux Corporation GNLX | FY2025 | $8K | -$32.1M | N/A | $103.4M | — |
| Voyager Therapeutics, Inc. VYGR | FY2025 | $40.4M | -$119.7M | N/A | $95.2M | 59/100 |
Where NeOnc Technologies Holdings, Inc. Ranks
Frequently Asked Questions
NeOnc Technologies Holdings, Inc. (NTHI) reported $40K in total revenue for fiscal year 2025. This represents a -51.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
NeOnc Technologies Holdings, Inc. (NTHI) revenue declined by 51.8% year-over-year, from $83K to $40K in fiscal year 2025.
No, NeOnc Technologies Holdings, Inc. (NTHI) reported a net loss of $62.1M in fiscal year 2025.
NeOnc Technologies Holdings, Inc. (NTHI) recorded an outflow of $20.9M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
NeOnc Technologies Holdings, Inc. (NTHI) recorded an outflow of $20.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
NeOnc Technologies Holdings, Inc. (NTHI) had $2.8M in total assets as of fiscal year 2025, including both current and long-term assets.
NeOnc Technologies Holdings, Inc. (NTHI) invested $500K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
NeOnc Technologies Holdings, Inc. (NTHI) invested $3.6M in research and development during fiscal year 2025.
NeOnc Technologies Holdings, Inc. (NTHI) had a current ratio of 0.07 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
NeOnc Technologies Holdings, Inc. (NTHI) had a return on assets of -2200.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
NeOnc Technologies Holdings, Inc. (NTHI) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $90.9M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
NeOnc Technologies Holdings, Inc. (NTHI) has no price-to-sales ratio at the moment: outside the range published as a multiple (on $40K revenue, FY2025). The market capitalization is $90.9M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, NeOnc Technologies Holdings, Inc. (NTHI) held $59K in cash, cash equivalents and investments, and reported an operating cash outflow of $20.4M over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
NeOnc Technologies Holdings, Inc. (NTHI) has negative shareholder equity of -$17.5M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
NeOnc Technologies Holdings, Inc. (NTHI) has an Altman Z-Score of -129.20, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
NeOnc Technologies Holdings, Inc. (NTHI) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
NeOnc Technologies Holdings, Inc. (NTHI) reported a net loss of $62.1M while operations used $20.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
NeOnc Technologies Holdings, Inc. (NTHI) reported an operating loss of $58.2M against $2.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.